In a xenograft tumor model, abrogation of TGFβ signaling led to increased colon cancer cell proliferation, decreased apoptosis and enhanced tumor growth in vivo, associated with elevated expression and activation of IRS-1. The gene discussed is TGFB1; the disease is malignant colon neoplasm.